Acute care and secondary prevention of stroke with newly detected versus known atrial fibrillation

Wang R, Macha K, Haupenthal D, Gaßmann L, Siedler G, Stoll S, Fröhlich K, Köhn J, Schwab S, Kallmünzer B (2022)

Publication Type: Journal article

Publication year: 2022

Journal

European Journal of Neurology Wiley-Blackwell

Abstract

Background and purpose: Atrial fibrillation (AF) in stroke patients can be classified as either “known AF” (KAF), defined as AF confirmed before stroke onset, or “AF detected after stroke” (AFDAS), defined as AF diagnosed after stroke onset. While KAF is considered primarily cardiogenic, AFDAS includes patients with stroke-triggered neurogenic arrhythmias. This study aimed to investigate the clinical course of stroke, functional outcomes and the value of oral anticoagulation (OAC) for secondary prevention according to AF subtype. Methods: Acute ischemic stroke patients were consecutively enrolled and AF was classified as AFDAS or KAF. Stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS) and 3-month functional outcomes were measured on the modified Rankin scale. Inverse probability weighting was applied to adjust for baseline confounders in patients with AFDAS and KAF. Multivariate logistic regression models were calculated to investigate the value of OAC for secondary prevention. Results: A total of 822 stroke patients with AF were included, of whom 234 patients (28.5%) had AFDAS. AFDAS patients had a lower prevalence of coronary artery disease, heart failure, and sustained AF, but higher rates of large vessel occlusion compared to KAF patients. NIHSS scores were lower in patients on pre-stroke anticoagulation. OAC for secondary prevention was associated with favorable 3-month functional outcome (odds ratio 7.60, 95% confidence interval 3.42–16.88) independently of AF subtype. The rate of stroke recurrence did not differ significantly. Conclusions: Clinical characteristics suggest that AFDAS might comprise a distinct pathophysiological and clinical entity among stroke patients with AF. The benefit of anticoagulation for secondary prevention was not affected by AF subtype.

Authors with CRIS profile

Ruihao Wang Department of Neurology Kosmas Macha Department of Neurology David Haupenthal Medizinische Fakultät Luise Biburger Department of Neurology Gabriela Siedler Department of Neurology Svenja Kremer Professur für Stammzell-Modelle seltener neuraler Erkrankungen Kilian Fröhlich Department of Neurology Julia Köhn Medizinische Fakultät Stefan Schwab Lehrstuhl für Neurologie Bernd Kallmünzer Department of Neurology

How to cite

APA:

Wang, R., Macha, K., Haupenthal, D., Gaßmann, L., Siedler, G., Stoll, S.,... Kallmünzer, B. (2022). Acute care and secondary prevention of stroke with newly detected versus known atrial fibrillation. European Journal of Neurology. https://dx.doi.org/10.1111/ene.15338

MLA:

Wang, Ruihao, et al. "Acute care and secondary prevention of stroke with newly detected versus known atrial fibrillation." European Journal of Neurology (2022).

BibTeX: Download